Marijuana Stocks & Public Companies

Marijuana Business Stock Ticker

Chris Walsh  | April 30, 2015
More than 100 marijuana stocks are currently listed on NASDAQ. Click to see our chart of the most relevant ones.

Week In Review: Detroit crackdown, NYSE listing bid & LSU proposes big bucks on MMJ

Bart Schaneman  | October 21, 2016

By Bart Schaneman, Omar Sacirbey and John Schroyer

Detroit cracks down on dispensaries, a cannabis real estate investment trust eyes a Big Board listing, and Louisiana State University proposes spending millions on medical marijuana cultivation.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

Another Canadian MMJ cultivator plans to go public

Bart Schaneman  | October 14, 2016

Canadian medical cannabis producer Emblem is set to go public next month on the TSX Venture Exchange, the electronic exchange owned by the parent of the Toronto Stock Exchange.

The Ontario company is the latest federally licensed medical marijuana cultivator to list its shares on an exchange, thanks to Canada’s legalized MMJ industry.

Emblem …

Week in Review: San Diego crackdown, WA eyes organic marijuana & Britain says yes to CBD

John Schroyer  | October 14, 2016

By Bart Schaneman and John Schroyer

San Diego targets illegal dispensaries while educating consumers about legit operations, Washington State has an eye toward organic certification, and Britain gives CBD the medicinal green light.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

Cultivator Aurora Cannabis raises 25M Canadian dollars

Omar Sacirbey  | October 11, 2016

Alberta, Canada-based medical marijuana cultivator Aurora Cannabis announced Tuesday that it plans to raise 25 million Canadian dollars ($19 million) in a private placement of convertible debentures.

The debt instruments mature in two years and can be converted into shares priced at CA$2.

Under the terms of the private placement, Aurora said in …

MassRoots pays off March debt of nearly $1M

John Schroyer  | October 7, 2016

MassRoots, the publicly traded cannabis-centric social media site, said Friday it has repaid its creditors after disclosing last month it had missed nearly $1 million in payments that were due to holders of its convertible notes.

“We’re excited to have this debt fully repaid and behind us. We expect MassRoots will be cash-flow …

Week in Review: MassRoots’ woes, GW Pharma’s good news & pro-legalization polls

Omar Sacirbey  | September 30, 2016

By Omar Sacirbey and John Schroyer

MassRoots lands in financial hot water, GW Pharmaceuticals takes a step closer to winning U.S. approval for its marijuana-based drug, and a political veteran urges caution heading into the elections.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

GW Pharma’s latest clinical trial successful, stock soars

John Schroyer  | September 27, 2016

British cannabis company GW Pharmaceuticals has conducted a successful clinical trial in which it treated epileptic children with one of its marijuana-based drugs, triggering a surge in the company’s stock price.

According to Reuters, tested doses of GW Pharmaceutical’s drug Epidiolex “were found to have induced a statistically significant improvement in reducing seizures” …

Medical Marijuana Inc. partners with CannaNative on CBD product

John Schroyer  | August 15, 2016

California-based Medical Marijuana Inc. and Native American company CannaNative have put together a hemp-derived CBD product line to be sold on tribal lands.

The companies said in a news release Monday that Medical Marijuana Inc. and its HempMeds subsidiary will produce the product line, which will be sold under the CannaNative brand.

It will …

Canadian cannabis company’s move to large stock exchange could create positive ripple effect

Omar Sacirbey  | August 10, 2016

By Omar Sacirbey

Canada-based Canopy Growth recently made history when it began trading on the Toronto Stock Exchange, becoming the first marijuana cultivator to list on a major North American exchange.

The move could spur more Canadian – and possibly even U.S. – medical cannabis companies to list on the exchange, one of the world’s largest.